NeuBase Therapeutics マネジメント
マネジメント 基準チェック /14
現在、CEO に関する十分な情報がありません。
主要情報
Todd Branning
最高経営責任者
n/a
報酬総額
CEO給与比率 | n/a |
CEO在任期間 | 2.3yrs |
CEOの所有権 | 0.04% |
経営陣の平均在職期間 | データなし |
取締役会の平均在任期間 | 3.5yrs |
経営陣の近況
Recent updates
Can NeuBase Therapeutics (NASDAQ:NBSE) Afford To Invest In Growth?
Aug 26NeuBase Therapeutics GAAP EPS of -$0.26 beats by $0.04
Aug 11NeuBase Therapeutics promotes Dr. William Mann to President and COO
Jun 29We Think NeuBase Therapeutics (NASDAQ:NBSE) Needs To Drive Business Growth Carefully
May 12Is NeuBase Therapeutics (NASDAQ:NBSE) In A Good Position To Deliver On Growth Plans?
Jan 24Here's Why We're Not Too Worried About NeuBase Therapeutics' (NASDAQ:NBSE) Cash Burn Situation
Oct 02Here's Why We're Not Too Worried About NeuBase Therapeutics' (NASDAQ:NBSE) Cash Burn Situation
Jun 02Have Insiders Been Buying NeuBase Therapeutics, Inc. (NASDAQ:NBSE) Shares This Year?
Feb 23We Think NeuBase Therapeutics (NASDAQ:NBSE) Can Afford To Drive Business Growth
Jan 19NeuBase Therapeutics EPS in-line
Dec 23NeuBase Therapeutics reports encouraging data for PATrOL-enabled anti-gene in a type of muscular dystrophy
Dec 16Do Insiders Own Lots Of Shares In NeuBase Therapeutics, Inc. (NASDAQ:NBSE)?
Dec 15CEO報酬分析
日付 | 総報酬 | 給与 | 会社業績 |
---|---|---|---|
Mar 31 2023 | n/a | n/a | -US$25m |
Dec 31 2022 | n/a | n/a | -US$30m |
Sep 30 2022 | US$922k | US$311k | -US$34m |
報酬と市場: Toddの 総報酬 がUS市場の同規模の企業と比較して妥当かどうかを判断するにはデータが不十分です。
報酬と収益: Toddの報酬と会社の業績を比較するにはデータが不十分です。
CEO(最高経営責任者
Todd Branning (53 yo)
2.3yrs
在職期間
US$922,445
報酬
Mr. Todd P. Branning serves as an Interim Chief Executive Officer since January 16, 2024 and Chief Financial Officer of NeuBase Therapeutics, Inc. since January 2022 and serves as its Secretary. He joined...
取締役
名称 | ポジション | 在職期間 | 報酬 | 所有権 |
---|---|---|---|---|
Founder | 4.8yrs | US$1.15m | 6.14% $ 87.1k | |
Independent Chairperson | 4.8yrs | US$74.42k | 0.040% $ 567.0 | |
Independent Director | 4.8yrs | US$68.38k | 0.060% $ 849.3 | |
Chairperson of Gene Editing Advisory Board & Member of Scientific Advisory Board | less than a year | データなし | データなし | |
Member of Gene Editing & Scientific Advisory Board | 4.6yrs | データなし | データなし | |
Member of Gene Editing Advisory Board | less than a year | データなし | データなし | |
Member of Scientific Advisory Board | 3.5yrs | データなし | データなし | |
Member of Advisory Board | no data | データなし | データなし | |
Chair of Scientific Advisory Board | no data | データなし | データなし | |
Member of Gene Editing & Scientific Advisory Board | 3.6yrs | データなし | データなし | |
Member of Gene Editing & Scientific Advisory Board | 3.5yrs | データなし | データなし | |
Independent Director | 3yrs | US$59.79k | 0% $ 0 |
3.5yrs
平均在職期間
56yo
平均年齢
経験豊富なボード: NBSEの 取締役会 は 経験豊富 であると考えられます ( 3.5年の平均在任期間)。